Platelet activating factor antagonists
Patent 5382670 Issued on January 17, 1995. Estimated Expiration Date: 
July 7, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 7, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPlatelet activating antagonists Patent #: 5120749 Inventors
ApplicationNo. 084257 filed on 07/07/1993US Classes:514/339, Ring nitrogen in the polycyclo ring system546/277.4, Bicyclo ring system which is indole (including hydrogenated)546/277.7, Chalcogen attached directly to the five-membered hetero ring by nonionic bonding546/278.1Having -C(=X)-, wherein X is chalcogen, bonded directly to the five- membered hetero ringExaminersPrimary: Ivy, C. WarrenAssistant: Mach, D. Margaret M. Attorney, Agent or FirmInternational ClassesC07D 213/04C07D 209/04 C07D 277/04 AbstractIndole compounds substituted at the 1- or 3-position by a (pyrid-3-yl)thiazolid-4-yl)alkyl-, (pyrid-3-yl)thiazolid-4-oyl)-, (pyrid-3-yl)dithiolan-4-yl)alkyl- or (pyrid-3-yl)dithiolan-4-oyl)- group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including septic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.Field of SearchRing nitrogen in the polycyclo ring system |
| ||||||||||||||
